Literature DB >> 20477589

Roles and mechanism of natural killer cells in clinical and experimental transplantation.

Suraksha Agrawal1, Piyush Tripathi, Sita Naik.   

Abstract

Natural killer (NK) cells are an important component of the innate immune response against intracellular pathogens and also play a role in the tissue inflammation associated with autoimmune diseases. Being a potent effector response, it must be well regulated in order to avoid unwanted destruction of normal tissues. Indeed, NK cells are unique in bearing both stimulatory and inhibitory receptor tolerance. The fine balance between activation and inhibition that decides their final action provides an opportunity for their possible modulation in specific therapeutic settings. The recent evidence implicating NK cells in promoting tolerance during allotransplantation is one such setting that has important implications for a successful transplant. This review provides an insight into NK cell biology and their involvement in allotransplant tolerance.

Entities:  

Year:  2008        PMID: 20477589     DOI: 10.1586/1744666X.4.1.79

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  3 in total

1.  Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia.

Authors:  Le Jie Lee; Norfarazieda Hassan; Siti Zuleha Idris; Suresh Kumar Subbiah; Heng Fong Seow; Norhafizah Mohtaruddin; Kian Meng Chang; Raudhawati Osman; Hishamshah Mohd Ibrahim; Sheila Nathan; Maha Abdullah
Journal:  J Immunol Res       Date:  2022-05-23       Impact factor: 4.493

2.  Impact of killer immunoglobulin-like receptor-human leukocyte antigens ligand incompatibility among renal transplantation.

Authors:  S Alam; D Rangaswamy; S Prakash; R K Sharma; M I Khan; A Sonawane; S Agrawal
Journal:  Indian J Nephrol       Date:  2015 Jan-Feb

3.  Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans.

Authors:  Wiebke Naujoks; Dagmar Quandt; Anja Hauffe; Heike Kielstein; Ina Bähr; Julia Spielmann
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.